斯德哥尔摩国际和平研究所-Emerging-dual_16页_731kb

Summary of "EMERGING DUAL-USE TECHNOLOGIES IN THE LIFE SCIENCES: CHALLENGES AND POLICY RECOMMENDATIONS ON EXPORT CONTROL"

Core Content

This policy paper examines the challenges and policy implications of regulating emerging dual-use technologies in the life sciences, particularly in the context of export control and non-proliferation. It emphasizes the need for a balanced approach that prevents the misuse of these technologies for the development of weapons of mass destruction (WMD), while also safeguarding the freedom of scientific research.

Main Points

1. Emerging Technologies and Dual-Use Risks

• Emerging technologies such as synthetic biology, genome editing (e.g., CRISPR/Cas9), and nanotechnology have significant potential for both civilian and military applications.
• These technologies can be misused to create biological or chemical weapons, posing risks to national security and international peace.
• The term "dual-use" refers to items, technologies, or knowledge that can be used for both peaceful and harmful purposes.
• The Biological and Toxin Weapons Convention (BWC) and the Chemical Weapons Convention (CWC) aim to prevent the development and use of WMD, but they do not explicitly cover all emerging dual-use technologies.

2. Challenges for Export Control

• Traditional export control mechanisms struggle to keep pace with the rapid development of emerging technologies.
• There is no universally accepted definition or clear criteria for identifying dual-use items, making it difficult to implement effective export controls.
• The Australia Group (AG) and the Wassenaar Arrangement (WA) are key international export control regimes, but they lack specific guidelines for emerging technologies.
• The EU's current export control system is being reviewed to address these challenges.

3. EU Export Control System

• The EU uses Council Regulation 428/2009 as the legal framework for dual-use export controls.
• The regulation includes a Control List of dual-use items and technologies, which is updated annually.
• Export licensing is primarily the responsibility of EU member states, though the EU plays a central role in coordination and oversight.
• The EU Dual Use Coordination Group (DUCG) supports the development of guidelines and the updating of the Control List.
• The EU reports on export denials and implementation of the dual-use regulation annually to the European Parliament and the Council.

4. EU Policy Strategies and Outreach

• The 2003 EU Strategy against Proliferation of Weapons of Mass Destruction recognizes the growing threat of WMD and the role of dual-use technologies.
• The Council Conclusions and new lines for action (NLA) from 2008 call for a coordinated approach to biosafety and biosecurity.
• The EU has implemented capacity-building programmes and outreach initiatives to support non-proliferation efforts, including:
  • Assistance in the implementation of the BWC.
  • Education and awareness-raising for scientists and institutions.
  • Partnerships with the private sector and international organizations.
  • The CBRN Risk Mitigation Centres of Excellence initiative supports 56 partner countries.

5. Examples of Emerging Dual-Use Technologies

a. Genetic Engineering Technologies (e.g., CRISPR/Cas9)

• CRISPR/Cas9 allows for precise, efficient genome editing and has revolutionized biotechnology.
• It has potential military applications, such as the development of harmful biological agents.
• Its widespread availability and connection to basic research make it challenging to control.
• Experts suggest focusing on the intention and end-use of research rather than restricting scientific progress.

b. Synthetic Biology

• Synthetic biology involves designing and constructing new biological systems or modifying existing ones.
• It has the potential to create biological agents that could be used in WMD development.
• The EU and other regimes are still working to define and control synthetic biology due to its broad applications and unclear risks.

Key Recommendations

• Develop harmonized, internationally recognized criteria for classifying emerging dual-use technologies.
• Enhance cooperation between the EU and third countries to improve export control systems.
• Promote transparency and outreach to raise awareness among scientists and institutions.
• Implement case-by-case risk assessments for dual-use technologies rather than blanket restrictions.
• Focus on end-use monitoring and strengthening biosecurity frameworks to prevent misuse without hindering scientific progress.

Conclusion

The paper underscores the importance of a nuanced and adaptive approach to export control in the life sciences. It highlights the need for the EU to update its regulatory framework, improve cooperation, and ensure that scientific freedom is preserved while mitigating the risks of misuse. The convergence of biology and emerging technologies presents both opportunities and challenges for non-proliferation and arms control.